Fri, Nov 28, 2014, 6:16 AM EST - U.S. Markets open in 3 hrs 14 mins

Recent

% | $
Quotes you view appear here for quick access.

Spectrum Pharmaceuticals, Inc. Message Board

  • richjaso2012 richjaso2012 Mar 21, 2013 4:25 AM Flag

    Analyst estimate update

    For 2013 Yahoo shows a loss of 27c versus profit of $1.47 recently, down $1.75. Huge drop.
    2014 is estimated at break even, 2c profit.

    Revenue is estimated to be around Mil 171.

    Still a huge spread within the analyst community.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • AND my I add AND they are estimating loss in the next 2 quarters ( on average ).. I just do not see how you can announce a -40%+ revenure SHORTFALL with PRICE CUTTING PRESSURES and turn a profit? Raj the MAGICIAN obviously lost a trick or too versus the generic COMPETITION.. AND I might add AND I do not see where if your wholesalers stopped ordering because the END USERS STOPPED buying in the same QUANTITY as before the software that tracts the end users will fix the problem? The problem is the end users demand is only buying $80m - $90m instead of the $214m 2013 Fusilev record sales. LETS SEE what the sales will be for Folotyn and Zevalin? LETS SEE if Raj the MAGICIAN can work some of his MAGIC on Zevalin like he has been PUMPING? LETS SEE if the NEW ( overstaffed ) DREAM SALES TEAM can increase Folotyn sales? Keller has his work cut out for him. For all those long the Matrix is BLINDLY CHEERING for you... I hope and pray that SPPI can stick to the $170m middle guidance and turn A PROFIT!!!

 
SPPI
7.38+0.02(+0.27%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.